AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s DiseaseActive ...
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.
Researchers have developed a method to analyze extracellular vesicles (EVs) in blood for early detection of Parkinson’s ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Patients from Part 2 will be evaluated for the progression of motor and non-motor symptoms and digital ... validated ...
The study suggests that hearing loss could also be an early symptom ... According to the NHS, the three main symptoms of Parkinson's disease are: tremor – shaking, which usually begins in ...